NCT06492304 2026-04-03A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic MalignanciesCRISPR TherapeuticsPhase 1/2 Completed12 enrolled
NCT05665530 2026-01-26A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic MalignanciesPrelude TherapeuticsPhase 1 Completed86 enrolled